{"componentChunkName":"component---src-templates-study-details-page-js","path":"/en/study/206221","result":{"data":{"studyNotFoundJson":{"title":"Study not found","content":{"childMarkdownRemark":{"html":"<p>If you entered a web address please check it was correct.</p>\n<p>You can also try <a href=\"/en/studies\">Search Page</a> to find the study you are looking for.</p>"}}},"trialDetailsJson":{"title":"Details Page","returnSearch":"Back to search results","description":"Study Description","identifier":"ViiV Study ID","clinicalID":"Clinicaltrials.gov Identifier","EudraCtID":"EudraCT Number","resultsAvailable":"Has Results Available Below","docAvailable":"Has Results Document Available","studyOverview":"Study Overview","overviewSection":{"conditionsDisplay":"Medical Conditions","product":"Product","collaborators":"Collaborators","dates":"Date","studyType":"Type","phase":"Phase","gender":"Gender","age":"Age","acceptVolunteers":"Accepts Healthy Volunteers"},"studyDocuments":"Study Documents","noDocuments":"No documents available","studyDocumentsAdditionalText":"If you wish to request for Full Study Report, please contact - ","studyDocumentsAdditionalEmail":"GSKClinicalSupportHD@gsk.com","isReleased":{"firstPart":"This study has Protocol and Result summary on ClinicalTrial.gov. Click","secondPart":"to learn more.","linkText":"here"},"mapLocations":"Locations","centralContact":"Central Contact","centralPhone":"Central Contact Phone","centralEmail":"Central Contact Email","mapSection":{"site":"GSK Investigational Site","condition":"Condition","id":"Study ID","city":"City","state":"State","zip":"Zip","country":"Country"},"studyDesign":"Study Design","designSection":{"purpose":"Primary Purpose","allocation":"Allocation","study_design":"Study Design","study_classification":"Study Classification","masking":"Masking","masked_subject":"Masked Subject","masked_caregiver":"Masked Caregiver","masked_investigator":"Masked Investigator","masked_assessor":"Masked Assessor","primary_outcomes":"Primary Outcomes","secondary_outcomes":"Secondary Outcomes","arms":"Arms","interventions":"Interventions","keyword":"Keyword","inclusionTitle":"Inclusion Criteria","exclusionTitle":"Exclusion Criteria","criteriaText":"Inclusion/Exclusion Criteria","criteria_button":"Click to view inclusion/exclusion criteria","enrollment":"Enrollment","clinicalPublications":"Clinical Publications"},"popoversText":{"studyId":{"childMarkdownRemark":{"html":"<p>A unique number for a study given by ViiV.</p>"}},"ctGov":{"childMarkdownRemark":{"html":"<p>This number identifies the study on the US clinicaltrials.gov register. Click this link to go to the entry for this study on Clinicaltrials.gov where you will be able to see protocol and results summaries where available.</p>"}},"eudraCT":{"childMarkdownRemark":{"html":"<p>This number identifies the study on the EU clinicaltrials.eu register. Click this link to go to the entry for this study on clinicaltrials.eu where you will be able to see protocol and results summaries where available.</p>"}}}},"site":{"siteMetadata":{"siteUrl":"https://www.viiv-studyregister.com"}},"studyDetails":{"nct_number":"NCT02273947","ctis_id":"","HasResults":"false","IpdAccessCriteria":"","IpdDescription":"","IpdInfoTypeAnalyticCode":"","IpdInfoTypeIcf":"","IpdInfoTypeCsr":"","IpdInfoTypeProtocol":"","IpdInfoTypeSap":"","IpdTimeFrame":"","IpdUrl":"","IsFlexibleTrial":false,"IsReleasedToCtGov":"true","MaskingInfo":{"masked_assessor":"false","masked_caregiver":"false","masked_investigator":"false","masked_subject":"false","masking_description":"","no_masking":"true"},"PatientLevelData":"false","SharingIpd":"None","acronym":"","allocation":"Randomized","arm_groups":[{"arm_group_label":"Arm 1 (ABDC): BMS-955176","arm_group_description":"BMS-955176 single dose by mouth for each treatment as specified","arm_type":"Experimental"},{"arm_group_label":"Arm 2 (BCAD): BMS-955176","arm_group_description":"BMS-955176 single dose by mouth for each treatment as specified","arm_type":"Experimental"},{"arm_group_label":"Arm 3 (CDBA): BMS-955176","arm_group_description":"BMS-955176 single dose by mouth for each treatment as specified","arm_type":"Experimental"},{"arm_group_label":"Arm 4 (DACB): BMS-955176","arm_group_description":"BMS-955176 single dose by mouth for each treatment as specified","arm_type":"Experimental"},{"arm_group_label":"Arm 5 (EFHG): BMS-955176","arm_group_description":"BMS-955176 single dose by mouth for each treatment as specified","arm_type":"Experimental"},{"arm_group_label":"Arm 6 (FGEH): BMS-955176","arm_group_description":"BMS-955176 single dose by mouth for each treatment as specified","arm_type":"Experimental"},{"arm_group_label":"Arm 7 (GHFE): BMS-955176","arm_group_description":"BMS-955176 single dose by mouth for each treatment as specified","arm_type":"Experimental"},{"arm_group_label":"Arm 8 (HEGF): BMS-955176","arm_group_description":"BMS-955176 single dose by mouth for each treatment as specified","arm_type":"Experimental"},{"arm_group_label":"Arm 9 (IJK): BMS-955176","arm_group_description":"BMS-955176 single dose by mouth for each treatment specified","arm_type":"Experimental"},{"arm_group_label":"Arm 10 (JKI): BMS-955176","arm_group_description":"BMS-955176 single dose by mouth for each treatment specified","arm_type":"Experimental"},{"arm_group_label":"Arm 11 (KIJ): BMS-955176","arm_group_description":"BMS-955176 single dose by mouth for each treatment specified","arm_type":"Experimental"},{"arm_group_label":"Arm 12 (IKJ): BMS-955176","arm_group_description":"BMS-955176 single dose by mouth for each treatment specified","arm_type":"Experimental"},{"arm_group_label":"Arm 13 (JIK): BMS-955176","arm_group_description":"BMS-955176 single dose by mouth for each treatment specified","arm_type":"Experimental"},{"arm_group_label":"Arm 14 (KJI): BMS-955176","arm_group_description":"BMS-955176 single dose by mouth for each treatment specified","arm_type":"Experimental"},{"arm_group_label":"Arm 15 (LMN): BMS-955176","arm_group_description":"BMS-955176 single dose by mouth for each treatment specified","arm_type":"Experimental"},{"arm_group_label":"Arm 16 (OPQ): BMS-955176","arm_group_description":"BMS-955176 single dose by mouth for each treatment specified","arm_type":"Experimental"},{"arm_group_label":"Arm 17 (PQO): BMS-955176","arm_group_description":"BMS-955176 single dose by mouth for each treatment specified","arm_type":"Experimental"},{"arm_group_label":"Arm 18 (QOP): BMS-955176","arm_group_description":"BMS-955176 single dose by mouth for each treatment specified","arm_type":"Experimental"},{"arm_group_label":"Arm 19 (OQP): BMS-955176","arm_group_description":"BMS-955176 single dose by mouth for each treatment specified","arm_type":"Experimental"},{"arm_group_label":"Arm 20 (POQ): BMS-955176","arm_group_description":"BMS-955176 single dose by mouth for each treatment specified","arm_type":"Experimental"},{"arm_group_label":"Arm 21 (QPO): BMS-955176","arm_group_description":"BMS-955176 single dose by mouth for each treatment specified","arm_type":"Experimental"}],"assignment":"Crossover Assignment","brief_summary":"The purpose of this study is to assess the impact of a light meal, a standard meal, and a high fat meal on the PK of BMS-955176 MC tablet at a dose of 180 mg, relative to fasted conditions.","brief_summary_OneLinkTx":"","brief_title_OneLinkTx":"","brief_title":"Food Effect Study With BMS-955176","conditions":[{"DisplayValue":"Human Immunodeficiency Virus (HIV)","DisplayValue_OneLinkTx":"","InternalValue":"CON_HIV","LookupValue":"Infection, Human Immunodeficiency Virus","LookupValue_OneLinkTx":""}],"created_date":"09/15/2018 17:40:47","criteria":"Inclusion Criteria: - Healthy subjects as determined by no clinically significant deviation from normal in medical history, physical examinations, vital sign measurements, 12-lead ECG measurements, and clinical laboratory test results - Body mass index (BMI) of 18.0 to 32.0 kg/m2, inclusive. BMI = Weight (kg)/[Height (m)]2 - Men and women, ages 18 to 50 years, inclusive - Women must not be of childbearing potential, must not be breastfeeding Exclusion Criteria: - Any significant acute or chronic medical illness - History of cardiac disease or clinically significant cardiac arrhythmias - Current or recent (within 3 months of study drug administration) gastrointestinal disease - Any major surgery within 4 weeks of study drug administration - Any gastrointestinal surgery (including cholecystectomy) that could impact upon the absorption of study drug","detailed_description":"Primary Purpose Other: This study will assess the impact of a light meal, a standard meal, and a high fat meal on the pharmacokinetics (PK) of BMS-955176 micronized crystalline (MC) tablet at a dose of 180 mg relative to fasted conditions.","display_gender":"Both","display_gender_internal":"GENDER_ALL","display_phase":"Phase 1","display_phase_internal":"PHASE_1","display_status":"Completed","display_status_internal":"RECSTATUS_I_COMPLETED","endpoint":"","enrollment":"12","exclusion":"","gender":"All","gender_based":"","gender_description":"","healthy_volunteers":"Yes","id":"f0d37e25-24ed-546c-9d38-58654a3aff3f","internal":{"content":null,"contentDigest":"0880e9f846f9497c7ef09ef6c3a50199","description":null,"fieldOwners":null,"mediaType":null,"ignoreType":null,"owner":"default-site-plugin","type":"studyDetails"},"inclusion":"Inclusion Criteria: - Healthy subjects as determined by no clinically significant deviation from normal in medical history, physical examinations, vital sign measurements, 12-lead ECG measurements, and clinical laboratory test results - Body mass index (BMI) of 18.0 to 32.0 kg/m2, inclusive. BMI = Weight (kg)/[Height (m)]2 - Men and women, ages 18 to 50 years, inclusive - Women must not be of childbearing potential, must not be breastfeeding Exclusion Criteria: - Any significant acute or chronic medical illness - History of cardiac disease or clinically significant cardiac arrhythmias - Current or recent (within 3 months of study drug administration) gastrointestinal disease - Any major surgery within 4 weeks of study drug administration - Any gastrointestinal surgery (including cholecystectomy) that could impact upon the absorption of study drug","interventions":[{"arm_group_label":"Arm 9 (IJK): BMS-955176","intervention_description":"Single dose by mouth for each treatment specified","intervention_name":"BMS-955176","intervention_type":"Drug"},{"arm_group_label":"Arm 16 (OPQ): BMS-955176","intervention_description":"Single dose by mouth for each treatment specified","intervention_name":"BMS-955176","intervention_type":"Drug"},{"arm_group_label":"Arm 17 (PQO): BMS-955176","intervention_description":"Single dose by mouth for each treatment specified","intervention_name":"BMS-955176","intervention_type":"Drug"},{"arm_group_label":"Arm 11 (KIJ): BMS-955176","intervention_description":"Single dose by mouth for each treatment specified","intervention_name":"BMS-955176","intervention_type":"Drug"},{"arm_group_label":"Arm 5 (EFHG): BMS-955176","intervention_description":"Single dose by mouth for each treatment specified","intervention_name":"BMS-955176","intervention_type":"Drug"},{"arm_group_label":"Arm 15 (LMN): BMS-955176","intervention_description":"Single dose by mouth for each treatment specified","intervention_name":"BMS-955176","intervention_type":"Drug"},{"arm_group_label":"Arm 2 (BCAD): BMS-955176","intervention_description":"Single dose by mouth for each treatment specified","intervention_name":"BMS-955176","intervention_type":"Drug"},{"arm_group_label":"Arm 4 (DACB): BMS-955176","intervention_description":"Single dose by mouth for each treatment specified","intervention_name":"BMS-955176","intervention_type":"Drug"},{"arm_group_label":"Arm 14 (KJI): BMS-955176","intervention_description":"Single dose by mouth for each treatment specified","intervention_name":"BMS-955176","intervention_type":"Drug"},{"arm_group_label":"Arm 20 (POQ): BMS-955176","intervention_description":"Single dose by mouth for each treatment specified","intervention_name":"BMS-955176","intervention_type":"Drug"},{"arm_group_label":"Arm 19 (OQP): BMS-955176","intervention_description":"Single dose by mouth for each treatment specified","intervention_name":"BMS-955176","intervention_type":"Drug"},{"arm_group_label":"Arm 12 (IKJ): BMS-955176","intervention_description":"Single dose by mouth for each treatment specified","intervention_name":"BMS-955176","intervention_type":"Drug"},{"arm_group_label":"Arm 6 (FGEH): BMS-955176","intervention_description":"Single dose by mouth for each treatment specified","intervention_name":"BMS-955176","intervention_type":"Drug"},{"arm_group_label":"Arm 21 (QPO): BMS-955176","intervention_description":"Single dose by mouth for each treatment specified","intervention_name":"BMS-955176","intervention_type":"Drug"},{"arm_group_label":"Arm 10 (JKI): BMS-955176","intervention_description":"Single dose by mouth for each treatment specified","intervention_name":"BMS-955176","intervention_type":"Drug"},{"arm_group_label":"Arm 3 (CDBA): BMS-955176","intervention_description":"Single dose by mouth for each treatment specified","intervention_name":"BMS-955176","intervention_type":"Drug"},{"arm_group_label":"Arm 8 (HEGF): BMS-955176","intervention_description":"Single dose by mouth for each treatment specified","intervention_name":"BMS-955176","intervention_type":"Drug"},{"arm_group_label":"Arm 1 (ABDC): BMS-955176","intervention_description":"Single dose by mouth for each treatment specified","intervention_name":"BMS-955176","intervention_type":"Drug"},{"arm_group_label":"Arm 18 (QOP): BMS-955176","intervention_description":"Single dose by mouth for each treatment specified","intervention_name":"BMS-955176","intervention_type":"Drug"},{"arm_group_label":"Arm 13 (JIK): BMS-955176","intervention_description":"Single dose by mouth for each treatment specified","intervention_name":"BMS-955176","intervention_type":"Drug"},{"arm_group_label":"Arm 7 (GHFE): BMS-955176","intervention_description":"Single dose by mouth for each treatment specified","intervention_name":"BMS-955176","intervention_type":"Drug"}],"interventional_subtype":"Other","is_fda_regulated":false,"is_high_value":false,"is_ind_study":false,"keywords":[],"last_follow_up_date":"08/15/2016 00:00:00","links":[],"locations":[{"City":"Ruddington Fields","Latitude":"52.8807428","CountryDisplay":"United Kingdom","Longitude":"-1.1436635","Name":"GSK Investigational Site","StateDisplay":"Nottinghamshire","PostalCode":"NG11 6JS","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"}],"masking":"","maximum_age_raw":"50 years","maximum_age":"50","minimum_age":"18","minimum_age_raw":"18 years","modified_date":"10/01/2018 22:44:08","number_of_arms":"21","observational_design":{"biospecimen_description":"","biospecimen_retention":"","number_of_groups":"","observational_study_design":"","patient_registry":"","target_duration_quantity":"","target_duration_units":"","timing":""},"official_title":"An Open-Label, Randomized, Crossover Adaptive Design Study to Assess the Effect of Food on the Pharmacokinetics of BMS-955176 Administered as a Micronized Crystalline Tablet in Healthy Subjects","org_study_id":"206221","overall_contact":{"email":"GSKClinicalSupportHD@gsk.com","last_name":"Call Center","phone":"877-379-3718"},"overall_status":"Completed - Interventional","oversight_info":{"exported_from_us":"","fda_regulated_device":"No","fda_regulated_drug":"No","ped_postmarket_surv":"","has_dmc":false,"post_prior_to_approval":"","regulatory_authorities":[""]},"phase":"1","primary_compl_date":"08/15/2016 00:00:00","primary_outcomes":[{"outcome_description":"","outcome_measure":"Maximum observed plasma concentration (Cmax) for BMS-955176","outcome_time_frame":"Up to Day 4 of Period 4","outcome_safety_issue":null},{"outcome_description":"","outcome_measure":"Area under the plasma concentration-time curve from time zero to 72 hours post-dose [AUC(0-72)] for BMS-955176","outcome_time_frame":"Up to Day 4 of Period 4","outcome_safety_issue":null},{"outcome_description":"","outcome_measure":"Area under the plasma concentration-time curve from time zero extrapolated to infinite time [AUC(INF)] for BMS-955176","outcome_time_frame":"Up to Day 4 of Period 4","outcome_safety_issue":null},{"outcome_description":"","outcome_measure":"Plasma concentration at 24 hours post-dose (C24) for BMS-955176","outcome_time_frame":"Up to Day 4 of Period 4","outcome_safety_issue":null}],"product_name":"","product_name_OneLinkTx":"","secondary_ids":[],"secondary_outcomes":[{"outcome_description":"Safety and tolerability measured by incidence of AEs, serious AEs (SAEs), AEs leading to discontinuation and death, marked abnormalities in clinical laboratory tests, viral sign measurements, ECGs, and physical examination Adverse Events (AEs), Electrocardiogram (ECG)","outcome_measure":"Safety and tolerability","outcome_time_frame":"Up to 30 days post discontinuation of dosing","outcome_safety_issue":null}],"sponsors":{"investigator_affiliation":"","investigator_username":"","lead_sponsor":"ViiV Healthcare","collaborators":["GlaxoSmithKline"]},"start_date":"10/23/2014 00:00:00","study_type":"Interventional","therapeutic_area":"Infectious Diseases","citations":[],"is_section_801":null}},"pageContext":{"studyId":"206221"}},"staticQueryHashes":["162689979","3332233851","3729204765","3769354840","399703114"]}